[1]
K.Y. Byung, B.P. Jun, H.S. Chi, Hypolipidemic effect of an exo-biopolymer produced from a submerged mycelial culture of Hercium erinaceum. Biosci. Biotech. Bioch, 67 (2003)1292-1298.
DOI: 10.1271/bbb.67.1292
Google Scholar
[2]
D.M. Kim, C.W. Pyun, H.G. Ko, W.M. Park, Isolation of antimicrobial substances from Hericium erinaceum. Mycobiology 28 (2000)33-38.
DOI: 10.1080/12298093.2000.12015719
Google Scholar
[3]
T. Mizuno, H. Sation, T. Nishitoba, H. Kawagishi, Antitumor active substances from mushroom. Food Rev. Int. 11(1995) 23-61.
DOI: 10.1080/87559129509541018
Google Scholar
[4]
C.P. Liu, J.N. Fang, X.Q. Xiao, Structural characterization and biologyical activities of SC4, an acidic polysaccharide from Salvia chinensis. Acta Pharmacol. Sin. 23, (2002)162-166.
Google Scholar
[5]
J.L. Mau, H.C. Lin, S.F. Song, Antioxidant properties of several specialty mushrooms. Food Res. Int. 35(2002)519-526.
DOI: 10.1016/s0963-9969(01)00150-8
Google Scholar
[6]
S. Kuwahara, E. Morihiro, A. Nemoto, A. Hiramatsu, Synthesis and absolute configuration of cytotoxic fatty acid isolated from the mushroom Hericium erinaceum. Biosci. Biotech. Bioch. 56 (1992)1417-1419.
DOI: 10.1271/bbb.56.1417
Google Scholar
[7]
H. Kawagishi, A. Shimada, R. Shirai, K. Okamoto, F. Ojima, H. Sakamoto, Y. Ishiguro, S. Furukawa, Erimacines A, B, and C, strong stimulators of nerve growth factor(NGF) synthesis, from the mycelia of Hercium erinaceum. Tetrahedron Lett. 35(1994).
DOI: 10.1016/s0040-4039(00)76760-8
Google Scholar
[8]
E.W. Lee, K. Shizuki, S. Hosokawa, M. Suzuki, H. Suganuma, T. Inakuma, J. Li, M. Ohnishi-Kameyama, T. Nagata, S. Furukawa, H Kawagishi, Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum. Biosci. Biotech. Bioch. 64 (2000).
DOI: 10.1271/bbb.64.2402
Google Scholar
[9]
L. Lu, J.L. Li, Y.H. Cang, PCR-based sensitive detection of medicinal fungi Hericium species from ribosomal internal transcribed spacer(ITS) sequences. Biol. Pharm. Bull. 25(2002) 975-980.
DOI: 10.1248/bpb.25.975
Google Scholar
[10]
F. Porcheray, S. Viaud, A.C. Rimaniol, C. Leone, B. Samah, N. Dereuddre-Bosquet, Macrophage activation switching: An asset for the resolution of inflammation. Clin. Exp. Immunol. 142(2005) 481-489.
DOI: 10.1111/j.1365-2249.2005.02934.x
Google Scholar
[11]
P.P. Wasser, Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl. Microbiol. Biot. 60 (2002) 258-274.
Google Scholar
[12]
E.B. Shirling, D. Gottleib, (1966) Methods for characterization of Streptomyces species. Int. J. Syst. Bacteriol. 16, 313-340.
Google Scholar
[13]
K. Suetsuna, Y. Osajima, Cultural conditions for production of gariseorhodin by a culture of S. californicus JCM 6910. Suisan Diagakkakenkyn Hokoku, 38 (1990)17-22.
Google Scholar
[14]
N.R. Kreig, J.G. Holt, Bergey's Manual of Determinative Bacteriology, Vol. 4: Williams and Wilkins, Baltimore/London, 1989, pp.2451-2458.
Google Scholar
[15]
A. Chandra, M.G. Nair, Azalomycin F complex from S. hygroscopicus MSO/MN-4-75b. J. Antibiot. 48 (1995) 896-898.
Google Scholar
[16]
A.K. Corbett, Production of antibiotic. in: J. Bu'lock, B. Kristiansen (eds. ). Basic biotechnology. Academic Press, New York, 1987, pp.425-48.
Google Scholar